Release form, composition and packing Acipol
Capsules, capsule contents - dry biomass from light cream to cream-colored with sour milk smell. 1 capsule. live acidophilus Lactobacillus 10 million
CFU polysaccharide kefir grains 400 mcg Ingredients shell capsules: gelatin, iron oxide red, titanium dioxide.
Clinico-pharmacological group: drug regulating the balance of intestinal microflora.
Pharmacological action
The drug, which regulates the balance of intestinal microflora. Contained in the product and lactobacillus acidophilus polysaccharide kefir grains have antagonistic activity against pathogenic and opportunistic microorganisms. The drug has a corrective effect on intestinal microflora, enhances immune reactivity.
Pharmacokinetics
Data on the pharmacokinetics of the drug Atsipol not given.
Statement
Dysbacteriosis and conditions that lead to its development:
acute intestinal infections (dysentery, salmonellosis, rotavirus gastroenteritis);
chronic colitis;
enterocolitis infectious and noninfectious origin;
prolonged antibiotic therapy.
Dysbacteriosis and underweight, associated with:
active antibiotic therapy of pyo-septic diseases in infants;
chronic, protracted, recurrent respiratory diseases (bronchitis, pneumonia, including Pneumocystis carinii);
atopic dermatitis and other allergic symptoms.
Prevention of dysbiosis (increasing the total resistance of the body).
Dosing regimen
Daily dose and duration of treatment are determined individually, depending on age, severity and duration of disease and severity of dysbiosis.
Children aged 3 months to 3 years are designated by 1 capsule 2-3 times daily (with food), pre-slitting the capsule and dissolving the contents in the milk or boiled water.
Adults and children older than 3 years prescribed 1 capsule 3-4 times / day for 30 minutes before meals. With acute intestinal infections drug is prescribed for 5-8 days. Longer courses are prescribed for the treatment of children with the underweight due to chronic course of diseases associated with dysbiosis.
From prevention to Atsipol prescribed 1 capsule 1 time per day for 10-15 days. Repeated courses are held not earlier than 1 month after the previous treatment. Capsules taken orally as a whole, without chewing, drinking boiled water.
Side effect
Side effects when using Atsipola in recommended doses is not established.
Contraindications
Increased chuvstvitelnoct to the drug.
Pregnancy and lactation
Data on the use Atsipola during pregnancy and lactation (breastfeeding) is not available.
Cautions
Not suitable for use:
preparation, integrity of the inner packaging is broken;
medicine without marking or with fuzzy markings;
preparation with the physical properties (broken capsule form) in the presence of foreign inclusions;
drug expired.
Complaints to the drug should be sent to FSIS National Institute of Standardization and Control of Medical Biological Preparations. Tarasevich and address of the manufacturer.
Overdose
Currently, cases of drug overdose Atsipol were reported.
Drug Interactions
Drug interactions drug Atsipol not described.
Conditions and terms of
The drug should be stored and transported in accordance with the joint venture 3.3.2.1248-03 at or above 10 ° C. Shelf life - 2 years.
Capsules, capsule contents - dry biomass from light cream to cream-colored with sour milk smell. 1 capsule. live acidophilus Lactobacillus 10 million
CFU polysaccharide kefir grains 400 mcg Ingredients shell capsules: gelatin, iron oxide red, titanium dioxide.
Clinico-pharmacological group: drug regulating the balance of intestinal microflora.
Pharmacological action
The drug, which regulates the balance of intestinal microflora. Contained in the product and lactobacillus acidophilus polysaccharide kefir grains have antagonistic activity against pathogenic and opportunistic microorganisms. The drug has a corrective effect on intestinal microflora, enhances immune reactivity.
Pharmacokinetics
Data on the pharmacokinetics of the drug Atsipol not given.
Statement
Dysbacteriosis and conditions that lead to its development:
acute intestinal infections (dysentery, salmonellosis, rotavirus gastroenteritis);
chronic colitis;
enterocolitis infectious and noninfectious origin;
prolonged antibiotic therapy.
Dysbacteriosis and underweight, associated with:
active antibiotic therapy of pyo-septic diseases in infants;
chronic, protracted, recurrent respiratory diseases (bronchitis, pneumonia, including Pneumocystis carinii);
atopic dermatitis and other allergic symptoms.
Prevention of dysbiosis (increasing the total resistance of the body).
Dosing regimen
Daily dose and duration of treatment are determined individually, depending on age, severity and duration of disease and severity of dysbiosis.
Children aged 3 months to 3 years are designated by 1 capsule 2-3 times daily (with food), pre-slitting the capsule and dissolving the contents in the milk or boiled water.
Adults and children older than 3 years prescribed 1 capsule 3-4 times / day for 30 minutes before meals. With acute intestinal infections drug is prescribed for 5-8 days. Longer courses are prescribed for the treatment of children with the underweight due to chronic course of diseases associated with dysbiosis.
From prevention to Atsipol prescribed 1 capsule 1 time per day for 10-15 days. Repeated courses are held not earlier than 1 month after the previous treatment. Capsules taken orally as a whole, without chewing, drinking boiled water.
Side effect
Side effects when using Atsipola in recommended doses is not established.
Contraindications
Increased chuvstvitelnoct to the drug.
Pregnancy and lactation
Data on the use Atsipola during pregnancy and lactation (breastfeeding) is not available.
Cautions
Not suitable for use:
preparation, integrity of the inner packaging is broken;
medicine without marking or with fuzzy markings;
preparation with the physical properties (broken capsule form) in the presence of foreign inclusions;
drug expired.
Complaints to the drug should be sent to FSIS National Institute of Standardization and Control of Medical Biological Preparations. Tarasevich and address of the manufacturer.
Overdose
Currently, cases of drug overdose Atsipol were reported.
Drug Interactions
Drug interactions drug Atsipol not described.
Conditions and terms of
The drug should be stored and transported in accordance with the joint venture 3.3.2.1248-03 at or above 10 ° C. Shelf life - 2 years.
No comments:
Post a Comment